Learn how two studies from Denmark expand upon earlier U.S. work that first linked the medication with the eye disease.
The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...
The effects that a pause may have on your body may depend on why you're taking the medication in the first place.
Former President Bill Clinton was admitted to MedStar Georgetown University Hospital in Washington, D.C. on Monday with a ...
Two clinical trials investigating semaglutide (Ozempic, Wegovy) as an early Alzheimer's treatment are expected to wrap up in ...
Ozempic's meteoric rise has reshaped the landscape of healthcare, retail, and consumer behavior. Its initial popularity as a weight loss ...
Harvey Fierstein shared how he lost 120 pounds. He says he is a “great believer” in weight loss drugs like Zepbound and ...
The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...
The condition is more common in people who are overweight or obese. Similar to semaglutide treatments like Ozempic and Wegovy ...
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...
Semaglutide, the active ingredient in Ozempic and Wegovy, has been linked to a condition that can cause permanent vision loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback